Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease (Q45781641)

16 December 2017

title

Comparison of 11C-PiB and 18F-florbetaben for Aβ imaging in ageing and Alzheimer's disease (English)

1 reference

16 December 2017

0 references

5

1 reference

16 December 2017

Colin L. Masters

10

object named as

Colin L Masters

1 reference

16 December 2017

Victor L Villemagne

1

1 reference

16 December 2017

Rachel S Mulligan

2

1 reference

16 December 2017

Svetlana Pejoska

3

1 reference

16 December 2017

Kevin Ong

4

1 reference

16 December 2017

Graeme O'Keefe

6

1 reference

16 December 2017

J Gordon Chan

7

1 reference

16 December 2017

Kenneth Young

8

1 reference

16 December 2017

Henri Tochon-Danguy

9

1 reference

16 December 2017

Christopher C Rowe

11

1 reference

16 December 2017

publication date

8 March 2012

1 reference

16 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

16 December 2017

volume

39

1 reference

16 December 2017

page(s)

983-989

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-012-2088-x

exact match

0 references

cites work

The ART of loss: Abeta imaging in the evaluation of Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Imaging beta-amyloid burden in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Assessment of beta-amyloid in a frontal cortical brain biopsy specimen and by positron emission tomography with carbon 11-labeled Pittsburgh Compound B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C]PiB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

21 January 2018

Brain amyloid imaging

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Amyloid PET Ligands for Dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Imaging of amyloid beta in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Characterization of AZD4694, a novel fluorinated Abeta plaque neuroimaging PET radioligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Use of Florbetapir-PET for Imaging β-Amyloid Pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Frequency of stages of Alzheimer-related lesions in different age categories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Amyloid imaging with (18)F-florbetaben in Alzheimer disease and other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

A voxel-based morphometric study of ageing in 465 normal adult human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Visual assessment versus quantitative assessment of 11C-PIB PET and 18F-FDG PET for detection of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Frequent amyloid deposition without significant cognitive impairment among the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Neuropathology of older persons without cognitive impairment from two community-based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Longitudinal patterns of β-amyloid deposition in nondemented older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-012-2088-X

Relationship between atrophy and beta-amyloid deposition in Alzheimer disease

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22398958

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00259-012-2088-X

1 reference

16 December 2017

Dimensions Publication ID

0 references

1 reference

16 December 2017